Assertive Community Treatment for Alcohol Misuse Disorder Patients Who Are High Utilizers of Emergency Department Services
ARFA
1 other identifier
observational
300
0 countries
N/A
Brief Summary
Background Frequent attenders (FAs) at emergency department (ED) in Singapore hospitals have been increasing over the years. More than half of the FAs are reported to be alcohol-related frequent attenders (ARFA) and they were found to be using EDs unnecessarily. We aim to assess if there will be a difference in patient outcomes in terms of ED usage and cost-effectiveness by implementing an assertive community treatment (ACT) program to manage AFRAs. Methods This is a prospective, multi-centre, before-and-after, superiority and cohort study to assess the impact of ACT from 4 study sites. 200-300 patients will be recruited and followed up for 12 months. The primary objective of the study is to investigate whether there will be a reduction in AFRA ED attendances. The secondary objective is to estimate the change in total cost utilization. Conclusion/Significance All patients who are on ACT programme will be enrolled in this study. The study intervention will be used as a new mode of care at participating hospitals. We expect to see reduced alcohol addiction level, reduced isolation level, improved motivation and better overall health. With reduced alcohol-related hospital visits, we would also expect to see improved healthcare utilization by ARFAs which will lead to increased cost savings to the healthcare systems and decreased social costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2020
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2020
CompletedFirst Posted
Study publicly available on registry
June 25, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
ExpectedAugust 5, 2020
July 1, 2020
6 years
June 22, 2020
August 3, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Emergency Department (ED) attendance
The primary outcome will be the rate of ED visits when comparing the pre-intervention period (12 months) with the post-intervention period (12 months). We anticipate a 25% reduction because of the ACT intervention.
2 years
Secondary Outcomes (8)
Emergency Medical Services (EMS) 995 calls
2 years (12 months pre-intervention, 12 months post-intervention)
Sustained reduction in ED attendance and EMS calls
3 years (12 months pre-intervention, 24 months post-intervention)
Level of Alcohol Dependence by Christo Inventory of Substance-misuse services (CISS score)
6 months (Baseline and 6 months post-intervention)
UCLA 3-point Loneliness Scale
6 months (Baseline and 6 months post-intervention)
Overall cost savings per patient
2 years (12 months pre-intervention, 12 months post-intervention)
- +3 more secondary outcomes
Study Arms (1)
'Before' and 'After' Arm
Before Arm - This refers to the rate of Emergency Department visits in the pre-intervention period (12 months). After Arm - This refers to the rate of Emergency Department visits in the post-intervention period (12 months) following the START of intervention.
Interventions
Assertive Community Treatment (ACT) is part of a 6-month program ARFAs will undergo. ACT teams will engage with ARFAs on a dedicated schedule. Each visit would last an average of 60 minutes. There will not be a re-arrangement of no-show visits. ACT teams will re-engage the ARFA over the phone to plan for the next visit as per the schedule. In keeping with principles of ACT, ARFA's will be assertively sought out in the community and provided intensive engagement, with holistic and supportive care alongside a harm reduction approach. Care will also involve case management and involvement of SSA's. Each interaction during the treatment period will focus on various aspects covering physical health, mental health, and addiction
Eligibility Criteria
Singapore has a population of 5.7 million, served by 7 adult EDs. Based on unpublished data, we estimate a population of 200-300 patients who would meet the criteria to be classified as ARFA in Singapore. Our study will implement the community-based intervention in ARFAs from 4 adult EDs. Once patients are recruited, individual, identifiable 5-year historical data from the point of study enrolment will be obtained from the electronic medical records system. This data will include dates of ED visits and ED diagnosis. Each intervention site will recruit up to 32 patients per year. The ACT teams will see a maximum of 16 patients over a period of 6 months (Appendix 1). Four hospitals will participate in the study over a period of 4 years with different initiation dates at each site. The setting up of such a service requires on-site specialist guidance and the specialist addictions team from NAMS is only able to guide one hospital's ACT team at a time for a period of 12 months.
You may qualify if:
- Patients who are not on active follow-up at the National Addictions Management Service at the Institute of Mental Health (IMH).
- Patients who speak English or Mandarin.
- Patients who are 21 years of age or older.
- ≧2 SNOMED alcohol-related ED visits in last 12 months AND ≧5 Emergency Department visits (All-cause)
- Patients who are cognitively intact and able to understand and appreciate the contents of the consent.
You may not qualify if:
- Patients who are on active follow-up at the NAMS at the Institute of Mental Health (IMH).
- Patients who are uncontactable by phone AND through opportunistic recruitment.
- Patients who do not give consent.
- Patients who do not speak English or Mandarin.
- Patients who are under 21 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Hughes NR, Houghton N, Nadeem H, Bell J, McDonald S, Glynn N, Scarfe C, Mackay B, Rogers A, Walters M, Smith M, McDonald A, Dalton D. Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions. Frontline Gastroenterol. 2013 Apr;4(2):130-134. doi: 10.1136/flgastro-2012-100260. Epub 2013 Jan 23.
PMID: 23502815RESULTChristo G, Spurrell S, Alcorn R. Validation of the Christo Inventory for Substance-misuse Services (CISS): a simple outcome evaluation tool. Drug Alcohol Depend. 2000 May 1;59(2):189-97. doi: 10.1016/s0376-8716(99)00117-9.
PMID: 10891633RESULTBoh C, Li H, Finkelstein E, Haaland B, Xin X, Yap S, Pasupathi Y, Ong ME. Factors Contributing to Inappropriate Visits of Frequent Attenders and Their Economic Effects at an Emergency Department in Singapore. Acad Emerg Med. 2015 Sep;22(9):1025-33. doi: 10.1111/acem.12738. Epub 2015 Aug 18.
PMID: 26284824RESULTWu J, Siddiqui FJ, Mak CCM, Chua ISY, Thangayah JR, Tan EXX, Seet HY, Rao AK, Tan HY, Mohamed A, Hartman M, Leong BS, Ong MEH, Mao DR. Assertive community treatment for high-utilizing alcohol misuse patients: a before-and-after cohort study protocol. BMC Health Serv Res. 2024 Feb 28;24(1):256. doi: 10.1186/s12913-023-10516-5.
PMID: 38419049DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2020
First Posted
June 25, 2020
Study Start
August 1, 2020
Primary Completion
August 1, 2026
Study Completion (Estimated)
August 1, 2027
Last Updated
August 5, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share
As this involves a vulnerable patient group (Alcohol misuse patients) and a sensitive outcome (Alcohol addiction levels), there are no plans to share this individual-level data with other researchers